OKAI — EvokAI Creative Labs Share Price
Last trade - 00:00- CA$9.89m
- CA$8.68m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.77 | ||
| Price to Tang. Book | 33.49 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 774.25 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -13.71% | ||
| Return on Equity | -78.44% | ||
| Operating Margin | -14497.02% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
EvokAI Creative Labs Inc. is a MedTech artificial-intelligence-powered company. It is engaged in the development of transformational technologies for the modern health care sector. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. It offers its AI algorithms across the whole health care system, from hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations to medical professionals, patients, and healthy individuals, aiming at preventing and early detecting any kind of disease and protecting the aging genome. Its divisions include EvokAI Simulators, EvokAI Sensors, EvokAI Neurotrainer and EvokAI Medical. EvokAI Simulators combines cognitive neuroscience, virtual reality and artificial intelligence technologies to assess cognitive performance and spatial perception.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- April 25th, 2017
- Public Since
- May 9th, 2011
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 76,054,930
- Address
- 1600-609 Granville Street, VANCOUVER, V7Y 1C3
- Web
- https://www.evokailabs.com/
- Phone
- +1 7783318505
- Auditors
- Dale Matheson Carr-Hilton LaBonte LLP
Upcoming Events for OKAI
Similar to OKAI
Aurora Spine
TSX Venture Exchange
CardioComm Solutions
TSX Venture Exchange
Cloud DX
TSX Venture Exchange
Enablence Technologies
TSX Venture Exchange
Evome Medical Technologies
TSX Venture Exchange
FAQ
As of Today at 07:08 UTC, shares in EvokAI Creative Labs are trading at CA$0.13. This share price information is delayed by 15 minutes.
Shares in EvokAI Creative Labs last closed at CA$0.13 and the price had moved by -89.17% over the past 365 days. In terms of relative price strength the EvokAI Creative Labs share price has underperformed the Toronto Stock Exchange 300 Composite Index by -89.78% over the past year.
There is no consensus recommendation for this security.
EvokAI Creative Labs does not currently pay a dividend.
EvokAI Creative Labs does not currently pay a dividend.
EvokAI Creative Labs does not currently pay a dividend.
To buy shares in EvokAI Creative Labs you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.13, shares in EvokAI Creative Labs had a market capitalisation of CA$9.89m.
Here are the trading details for EvokAI Creative Labs:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: OKAI
Based on an overall assessment of its quality, value and momentum EvokAI Creative Labs is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like EvokAI Creative Labs. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -89.33%.
As of the last closing price of CA$0.13, shares in EvokAI Creative Labs were trading -88.14% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The EvokAI Creative Labs PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.13.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
EvokAI Creative Labs' management team is headed by:
- Scott Ackerman - PRE
- Brent Ackerman - IND
- Rick Cox - IND